A Parkinson's biotech debut, fundraising campaign and licensing deal
Plus news about Altis Labs, Matisse Pharmaceuticals, AstraZeneca, Novo, Longeveron, Connexus Therapeutics and Avacta. A new Parkinson’s biotech: The Michael J. Fox Foundation is supporting a non-hallucinogenic psychedelic at Ariadne Bio, a biotech that
September 17, 2026 11:28 AM EDT News Briefing A Parkinson's biotech debut, fundraising campaign and licensing deal ENDPOINTS Plus news about Altis Labs, Matisse Pharmaceuticals, AstraZeneca, Novo, Longeveron, Connexus Therapeutics and Avacta. A new Parkinson’s biotech: The Michael J. Fox Foundation is supporting … Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that